BRYTLY FDA approval date

The FDA approved BRYTLY on 16 Oct 2026.

FDA approval date
16 Oct 2026

Drug identity has not yet been verified against registry records

Also recorded as APRACLONIDINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-10-16DayBRYTLYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220341", "applicant_as_listed_by_fda": "ALCON LABS INC", "brand_names": ["BRYTLY"], "active_ingredients": ["APRACLONIDINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20261016", "matched_on": "drug record created from this FDA brand name"}

First seen: 02 Nov 2026 · Evidence last checked: 02 Nov 2026